SARS-CoV2 induced respiratory distress: Can cannabinoids be added to anti-viral therapies to reduce lung inflammation?

Brain Behav Immun. 2020 Jul:87:120-121. doi: 10.1016/j.bbi.2020.04.079. Epub 2020 Apr 28.
No abstract available

Keywords: Cannabinoids; Cytokine; Inflammation; Lung; Rhesus macaque; SARS-CoV2.

Publication types

  • Letter
  • Research Support, N.I.H., Extramural

MeSH terms

  • COVID-19*
  • Cannabinoids* / therapeutic use
  • Humans
  • Pneumonia* / drug therapy
  • RNA, Viral
  • Respiratory Distress Syndrome* / drug therapy
  • SARS-CoV-2

Substances

  • Cannabinoids
  • RNA, Viral